Aktie A14QR6 CANNAPHARMARX, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen CannaPharmaRX, Inc. Other OTC

Aktien

A14QR6

US13765D1090

CPMD

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CannaPharmaRX, Inc. Receives First Purchase Order and Begins Shipment of Product
CannaPharmaRX, Inc. Executes Multi-Year Supply Agreement with Ican to Create Distribution Network in the Latin Americas
CannaPharmaRx, Inc Enters into Strategic Supply Agreement with Cantek Holdings
CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CannaPharmaRX, Inc. Announces Executive Changes
CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CannaPharmaRx Expands Board of Directors
CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CannaPharmaRX, Inc. Announces CEO Changes
CannaPharmaRX, Inc. Signs Supply Agreement with Y.S.A Holdings for Up to $15 Million Annually of Commercial Cannabis
CannaPharmaRX, Inc. completed the acquisition of LTB Management LLC.
CannaPharmaRX, Inc. agreed to acquire LTB Management LLC.
CannaPharmaRx Receives Canada Revenue Agency License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million
CannaPharmaRx, Inc Receives Cultivation License from Health Canada and Projects 2023 Revenue over $30 Million
CannaPharmaRX, Inc. Provides Revenue Guidance for the Full Year 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14QR6 Aktie
  4. A14QR6 Aktie
  5. Nachrichten CannaPharmaRX, Inc.
  6. Andere Sprachen